AstraZeneca kicks off savings drive to invest in pipeline after sales beat
AstraZeneca kicks off savings drive to invest in pipeline after sales beat Oct 30 (Reuters) - AstraZeneca AZN.L on Friday announced a restructuring programme aimed at supporting pipeline investments with benefits of about $1.5 billion to keep the drugmaker on track to achieve its target of generating $80 billion in annual revenue by 2030.
The moves were announced alongside third-quarter results, which surpassed analyst expectations.
(Reporting by Pushkala Aripaka, Sri Hari N S in Bengaluru and Patrick Wingrove in London; Editing by Janane Venkatraman)
((Pushkala.A@thomsonreuters.com; X and LinkedIn: @pullthekart;))
Recent news on AstraZeneca
See all newsAstraZeneca fends off lawsuit over alleged Soliris drug monopoly (updated)
AstraZeneca fends off lawsuit over alleged Soliris drug monopoly
Sofinnova closes €725 million fund to back European biotech expansion
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
UK Stocks-Factors to watch on November 16 (updated)